Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Dihydroergotamine Mesylate 0.25% Nasal Spray is a liquid formulation delivered in a spray form for nasal administration. It is specifically designed to provide targeted local or systemic effects through the nostrils. This medication is used to treat conditions such as migraine, cluster headache, Meniere's disease, tension headache, and sinusitis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dihydroergotamine Mesylate 0.25% Nasal Spray is a prescription medication that is used to treat a variety of conditions. This includes migraines, cluster headaches, Meniere's disease, tension headaches, and sinusitis. It is a fast-acting, non-narcotic medication that works by constricting blood vessels in the brain and reducing inflammation. The medication is delivered in a liquid formulation via a nasal spray, specifically designed for administration into the nasal cavity. This method of delivery allows for targeted local or systemic effects through the nostrils, providing rapid relief of symptoms.
For migraines, Dihydroergotamine Mesylate 0.25% Nasal Spray is used to reduce the severity and duration of migraine attacks. In the case of cluster headaches, it is used to reduce the frequency and intensity of attacks. For Meniere's disease, it is used to reduce the severity of vertigo and tinnitus. For tension headaches, it is used to reduce the frequency and intensity of headaches. For sinusitis, it is used to reduce inflammation and congestion.
Dihydroergotamine Mesylate 0.25% Nasal Spray is generally well-tolerated, with few side effects. Common side effects include nausea, dizziness, and drowsiness. It is crucial to follow the instructions of your healthcare provider when taking this medication to ensure its effectiveness and to minimize potential side effects.
If you have any questions about Dihydroergotamine Mesylate 0.25% Nasal Spray or how it can help treat your condition, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need.
This Dihydroergotamine Mesylate 0.25% Nasal Spray is a compounded formulation specifically designed for the treatment of various conditions such as migraine, cluster headache, Meniere's Disease, tension headache, and sinusitis. It is a vasoconstrictor that functions by constricting the blood vessels in the brain, thereby reducing inflammation and pain associated with these conditions. It is also believed to decrease the production of certain brain chemicals that can trigger nausea and vomiting.
Furthermore, it has shown efficacy in reducing the symptoms of sinusitis, such as nasal congestion, facial pain, and pressure.
When using this nasal spray, it is crucial to adhere to the instructions provided by your healthcare provider. The recommended dosage is one spray in each nostril twice daily, or as directed by your healthcare provider. Please note that this formulation should not be used more than twice daily to avoid an increased risk of side effects. It is also advised to refrain from using this formulation if you are pregnant or breastfeeding, as it may potentially harm the fetus or infant.
If you have any queries or concerns about using this formulation, do not hesitate to contact your healthcare provider. They are there to assist you in making the best decisions for your health.
Dihydroergotamine Mesylate 0.25% Nasal Spray is a specialized liquid formulation, designed for intranasal administration. This prescription medication is primarily used for the treatment of conditions such as migraine, cluster headache, Meniere's disease, tension headache, and sinusitis. It functions by constricting the blood vessels in the brain, reducing inflammation, and limiting the release of certain substances that trigger pain, nausea, and other symptoms associated with these conditions.
The medication is delivered in a spray form, specifically designed for administration into the nasal cavity. This allows for targeted local or systemic effects through the nostrils. The spray is administered intranasally, meaning it is sprayed directly into the nose. It is crucial to adhere to the instructions provided by your healthcare provider when using this medication.
For conditions like migraine, cluster headache, and tension headache, the recommended dosage is one spray in each nostril, to be repeated every 4-6 hours as needed. In the case of Meniere's disease, the suggested dosage is one spray in each nostril, to be repeated every 8-12 hours as required. For sinusitis, the recommended dosage is one spray in each nostril, to be repeated every 12 hours as needed.
It is important to note that Dihydroergotamine Mesylate 0.25% Nasal Spray should not be used for more than 10 consecutive days. If symptoms persist beyond 10 days, it is advised to contact your healthcare provider. Additionally, this medication should be avoided if you are pregnant or breastfeeding, as it may potentially harm the fetus or infant.
If you have any queries or concerns regarding the use of Dihydroergotamine Mesylate 0.25% Nasal Spray, do not hesitate to reach out to your healthcare provider. They are equipped to provide you with the necessary guidance and support.
This Dihydroergotamine Mesylate 0.25% Nasal Spray is a compounded formulation specifically designed for the treatment of various conditions such as migraine, cluster headache, Meniere's disease, tension headache, and sinusitis. It is a liquid formulation that is administered directly into the nasal cavity, providing targeted local or systemic effects through the nostrils. It is crucial to understand that this formulation is not indicated for the treatment of any other conditions.
Patients should exercise caution when using this formulation as it may cause side effects such as drowsiness, dizziness, and blurred vision. It is advised not to operate heavy machinery or drive while taking this medication due to these potential side effects. Furthermore, this formulation should not be used in combination with other medications as it may increase the risk of adverse effects.
It is also important to note that this formulation may interact with certain medications, including monoamine oxidase inhibitors (MAOIs). Therefore, patients should consult their healthcare provider before starting this medication. If you have any questions or concerns regarding this formulation, please do not hesitate to reach out for further information.
Dihydroergotamine Mesylate 0.25% Nasal Spray is a liquid formulation delivered in a spray form. It is specifically designed for administration into the nasal cavity, providing targeted local or systemic effects through the nostrils.
This nasal spray works by delivering the medication directly into the nasal cavity. This allows for targeted local or systemic effects, depending on the specific needs of the patient.
You should use this nasal spray as directed by your healthcare provider. It is typically administered into the nostrils.
As with any medication, there may be potential side effects. You should consult with your healthcare provider for a complete list of potential side effects and what to do if you experience them.
Before using this nasal spray with other medications, you should consult with your healthcare provider to ensure there are no potential interactions.
You should store this nasal spray as directed by your healthcare provider or the product packaging. Typically, it should be stored at room temperature, away from light and moisture.
If you miss a dose of this nasal spray, you should take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take two doses at the same time.
If you believe you have overdosed on this nasal spray, seek medical attention immediately.
If you are pregnant or breastfeeding, you should consult with your healthcare provider before using this nasal spray to ensure it is safe for you and your baby.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Inhale intranasally
